Risk Factors and Management of Type 1 Diabetes

Type 1 diabetes (TID) is an organ-specific autoimmune disease in which the selective destruction of islet B cells mediated by the T lymphocytes leads to absolute insulin deficiency, especially result from the interaction between genetic and non-genetic factors which is prevalent among teenagers all over the world. However, there also a lot of challenge in clinical and the trigger of the T1D.This essay comprehensively review the currently study of etiology, epidemiology, and management of T1D. he essay mainly aim at understanding the theory of disease as the result of improve in the therapeutic schedule. Moreover, recent innovation in immunotherapy especially in specific islet immune pathways and innovations in non-invasive blood glucose monitoring technologies make the therapy for the patient more efficient and more. At the same time, it is hoped that there will be more relevant studies in the future to continuously improve the understanding of its heterogeneity and prognostic markers, and improve and develop treatment strategies and management methods, so as to benefit patients.

Authors

Institutions

Publication Details

Journal
Highlights in Science Engineering and Technology
Published
2024-12-24
DOI
https://doi.org/10.54097/t2vyt237
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk Factors and Management of Type 1 Diabetes

Jiawen Xu
Highlights in Science Engineering and Technology
Diabetes and associated disorders
article

Risk Factors and Management of Type 1 Diabetes

Jiawen Xu
article en

Abstract

Type 1 diabetes (TID) is an organ-specific autoimmune disease in which the selective destruction of islet B cells mediated by the T lymphocytes leads to absolute insulin deficiency, especially result from the interaction between genetic and non-genetic factors which is prevalent among teenagers all over the world. However, there also a lot of challenge in clinical and the trigger of the T1D.This essay comprehensively review the currently study of etiology, epidemiology, and management of T1D. he essay mainly aim at understanding the theory of disease as the result of improve in the therapeutic schedule. Moreover, recent innovation in immunotherapy especially in specific islet immune pathways and innovations in non-invasive blood glucose monitoring technologies make the therapy for the patient more efficient and more. At the same time, it is hoped that there will be more relevant studies in the future to continuously improve the understanding of its heterogeneity and prognostic markers, and improve and develop treatment strategies and management methods, so as to benefit patients.

Highlights in Science Engineering and TechnologyVol. 123
ISS International (South Africa) (ZA)
Good health and well-being
Openalex Percentile: Top 73%
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Risk Factors and Management of Type 1 Diabetes — Jiawen Xu · Highlights in Science Engineering and Technology (2024) | TGRS Research Map | TGRS